Navigation » List of Schools » International College of Health Sciences » Nursing » Nursing 1141- Pharmacology » Fall 2022 » Mastery EAQ Ch. 26
Below are the questions for the exam with the choices of answers:
Question #1
A The medication will be stopped.
B The dose will be increased.
C The dose will be decreased.
D The dose will be unchanged.
Question #2
A Is a candidate for fondaparinux based on a sufficient creatinine clearance and adequate body weight
B Not a candidate for fondaparinux based on both an insufficient creatinine clearance and an inadequate body weight
C Not a candidate for fondaparinux based on an insufficient creatinine clearance
D Is a candidate for fondaparinux based on sufficient creatinine clearance and after body weight attains an adequate level
Question #3
A Within normal limits
B Too high
C Inadequate to evaluate treatment
D Too low
Question #4
A Significantly elevated
B Inadequate to evaluate treatment
C Significantly decreased
D Within normal limits
Question #5
A Monitor liver enzymes.
B Administer prescribed vitamin K if bruising is observed.
C Assess for dysrhythmias.
D Stop the medication if the systolic blood pressure drops below 110 mm Hg.
Question #6
A Administering the medication intramuscularly in the vastus lateralis
B Checking if the patient’s prescription contains enoxaparin
C Administering the medication when convenient
D Massaging the site after the injection
Question #7
A “I take ginkgo supplements for memory enhancement.”
B “I refrain from drinking coffee and citrus fruit juices daily.”
C “I do not take aspirin for pain relief.”
D “I eat 1 cup of green leafy vegetables daily.”
Question #8
A “I never sit with my legs crossed at the knees.”
B “I avoid tight-fitting stockings or leggings.”
C “I’ve been on prolonged bed rest.”
D “I get up and walk around at least once an hour.”
Question #9
A Tranexamic acid
B Aminocaproic acid
C Phytonadione
D Alteplase
Question #10
A Carbamazepine
B Cimetidine
C Cholestyramine
D Barbiturate
Question #11
A Platelet count, Heart rate, Blood pressure
B Heart rate, Hemoglobin, Blood pressure
C Activated partial thromboplastin time (aPTT), Blood pressure, Heart rate
D Hemoglobin, Platelet count, Activated partial thromboplastin time (aPTT)
Question #12
A “I will take the medication with food.”
B “I will store the bottle in a dry place.”
C “I will place the pills in an organizer for easy use.”
D “I will use the medication within 60 days after it is opened.”
Question #13
A Platelet count of 80,000/mm3
B Creatinine clearance of 25 mL/min
C Diagnosis of diabetes mellitus
D Loss of 10 pounds
Question #14
A The dosage of the warfarin will be increased by half.
B The dosage of the amiodarone will be decreased by half.
C The dosage of the warfarin will be decreased by half.
D The dosage of the amiodarone will be increased by half.
Question #15
A Continue to administer cimetidine with each dose of warfarin.
B Monitor the patient for decreased action of the anticoagulant.
C Instruct the patient to notify the nurse if he or she begins to experience discomfort.
D Monitor the patient for increased action of the anticoagulant.
Question #16
A Local thrombosis from a peripheral intravenous line
B Severe chest pain for the past 2 hours
C Gastrointestinal bleed
D Peptic ulcer disease
Question #17
A Monitor the patient and check the therapeutic range.
B Notify the health care provider immediately.
C Increase the dose of heparin.
D Stop the medication.
Question #18
A Outside the expected target therapeutic level of anticoagulation; it is too high
B Outside the expected target therapeutic level of anticoagulation; it is too low
C Cannot be interpreted without knowing the prothrombin time and international normalized ratio
D Within the expected target therapeutic level of anticoagulation
Question #19
A Prothrombin time: 13 sec
B Leukocyte count: 3000 cells/mm3
C Hemoglobin level: 11 g/dL
D Platelet count: 100,000/mm3
Question #20
A Peptic ulcer disease, Chronic kidney disease
B Chronic obstructive pulmonary disease, Atrial fibrillation
C History of myocardial infarction, Chronic obstructive pulmonary disease
D Atrial fibrillation, History of myocardial infarction
Question #21
A Activated partial thromboplastin time (aPTT) of 37 seconds
B International normalized ratio (INR) of 1
C Platelet count of 95,000/mm3
D Potassium level of 3.5 mEq/L
Question #22
A Within the expected target therapeutic level of anticoagulation
B Outside the expected target therapeutic level of anticoagulation; it is too high
C The prothrombin time and activated partial thromboplastin time (aPTT) value are needed to interpret the finding.
D Outside the expected target therapeutic level of anticoagulation; it is too low
Question #23
A “Refrigerate and keep away from direct sunlight.”
B “Remove from the original package and place in aluminum foil.”
C “Discard the drug within 21 days of opening the original container.”
D “Store the drug with the desiccant-drying agent in the packing cap.”
Question #24
A Furosemide
B Ketoconazole
C Enoxaparin
D Amiodarone
Question #25
A Monitor the patient’s laboratory values correctly.
B Teach the patient about dietary restrictions while on the medication.
C Have protamine sulfate readily available at all times.
D Ensure that a loading dose was initially administered when beginning
Question #26
A Administer protamine sulfate IV.
B Stop the intravenous (IV) drip.
C Administer vitamin K1 (phytonadione) IV.
D Wait for the INR to decrease.
Question #27
A A quick decrease in pain
B Prevention of new clots from forming
C Dissolution of the clot that caused the heart attack
D Reversal of damage from the infarction
Question #28
A “I should not use any acetaminophen during the therapy.”
B “I should follow a low-cholesterol diet during the therapy.”
C “I should take oral contraceptives during the therapy.”
D “I should refrain from eating broccoli during the therapy.”
Question #29
A “I should keep taking ibuprofen for my arthritis.”
B “I should use a soft toothbrush for dental hygiene.”
C “I should decrease the dose if I start bruising easily.”
D “I will double my dose if I forget to take it the day before.”
Question #30
A “Dalteparin is a low-molecular-weight heparin that is more predictable in its effect and has a lower risk of bleeding.”
B “You should ask your doctor why dalteparin was ordered instead of regular heparin.”
C “The only difference is that regular heparin dosing is based on the patient’s weight.”
D “There is no real difference; dalteparin is interchangeable with regular heparin.”
Question #31
A Rub the administration site after injecting.
B Draw up the medication in a syringe with a 22-gauge, 1.5-inch needle.
C Administer the medication into subcutaneous tissue of the abdomen.
D Utilize the Z-track method to inject the medication.
Question #32
A “I will increase dark green leafy vegetables in my diet.”
B “I will take my medication at the same time each day.”
C “I will avoid contact sports.”
D “I will contact my health care provider if I develop excessive bruising.”
Question #33
A Calcium gluconate
B Protamine sulfate
C Vitamin K
D Vitamin E
Question #34
A Vitamin K daily
B Aspirin daily (i.e., 81 mg)
C Warfarin daily
D Recombinant factors
Question #35
A Transient ischemic attack
B Vitamin K deficiency
C Peripheral vascular disease
D Acute unstable angina
Question #36
A Warfarin orally
B Dabigatran orally
C Heparin subcutaneously
D Enoxaparin intramuscularly
Question #37
A Over-the-counter medications
B Ingestion of acetaminophen
C Urine culture
D Platelet level
Question #38
A September 15
B October 1
C August 29
D July 31
Question #39
A Edema
B Itching
C Nausea
D Chest pain
Question #40
A International normalized ratio (INR) of 1.0
B Blood urea nitrogen (BUN) level of 12 mg/dL
C Platelet count of 150,000 mm3
D Activated partial thromboplastin time (aPTT) of 120 seconds
Question #41
A Platelet count of 75,000 cell/μL
B Creatinine clearance value of 40 mL/min
C Hemoglobin level of 16.5 g/dL
D Fasting blood glucose level of 95 mg/dL
Question #42
A Vitamin K
B Factor Xa
C Antithrombin III
D Thrombin
Question #43
A Desmopressin
B Aminocaproic acid
C Alteplase
D Tranexamic acid
Question #44
A Anticoagulant
B Antiplatelet
C Thrombolytic
D Antifibrinolytic
Question #45
A Cardiomyopathy
B Coronary artery disease
C Acute myocardial infarction
D Heart failure
Question #46
A Pentoxifylline
B Aspirin
C Dipyridamole
D Cilostazol
Question #47
A Argatroban
B Fondaparinux
C Enoxaparin
D Dabigatran
Question #48
A Direct thrombin inhibitors
B Warfarin
C Heparins
D Selective factor Xa inhibitors
Question #49
A Anticoagulants dissolve clots.
B Anticoagulants interfere with drug metabolism.
C Anticoagulants prevent clots from forming.
D Anticoagulants alter platelet function.
Question #50
A Antifibrinolytic
B Anticoagulant
C Antiplatelet
D Thrombolytic
Question #51
A Fatigue from walking with pain
B Anxiety
C Embolus to the lungs
D Medication reaction
Question #52
A Infusing 50 mL of warfarin sodium
B Increasing the dose of enoxaparin
C Administering vitamin K1
D Administering protamine sulfate
Question #53
A Calcium
B Vitamin K
C Potassium
D Aspirin